Ekso Bionics Holdings, Inc. financial data

Symbol
EKSO on Nasdaq
Location
101 Glacier Point, Suite A, San Rafael, CA
State of incorporation
NV
Fiscal year end
December 31
Former names
PN Med Group Inc (to 12/31/2013)
Latest financial report
10-Q - Q2 2024 - Jul 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 264 % -19.3%
Quick Ratio 66.6 % +22.5%
Debt-to-equity 115 % +84.2%
Return On Equity -92.1 % -33.2%
Return On Assets -42.8 % -0.61%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.4M shares +33.6%
Common Stock, Shares, Outstanding 18.4M shares +33.6%
Entity Public Float 18.7M USD -0.77%
Common Stock, Value, Issued 19K USD +35.7%
Weighted Average Number of Shares Outstanding, Basic 18.2M shares +33.6%
Weighted Average Number of Shares Outstanding, Diluted 18.2M shares +33.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 4.73M USD +7.78%
Selling and Marketing Expense 7.7M USD -5.23%
General and Administrative Expense 8.96M USD -24.9%
Operating Income (Loss) -12M USD +28.8%
Nonoperating Income (Expense) -453K USD -163%
Net Income (Loss) Attributable to Parent -12.4M USD +22.8%
Earnings Per Share, Basic -0.79 USD/shares +34.7%
Earnings Per Share, Diluted -0.79 USD/shares +34.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.89M USD -55.8%
Accounts Receivable, after Allowance for Credit Loss, Current 6.52M USD +29.1%
Inventory, Net 4.97M USD -11.2%
Assets, Current 18.6M USD -24.6%
Property, Plant and Equipment, Net 1.75M USD -24.1%
Operating Lease, Right-of-Use Asset 989K USD -13.7%
Intangible Assets, Net (Excluding Goodwill) 4.74M USD -6.21%
Goodwill 431K USD 0%
Other Assets, Noncurrent 435K USD +31%
Assets 27M USD -20.6%
Accounts Payable, Current 2.13M USD -32.6%
Employee-related Liabilities, Current 1.46M USD -18.9%
Accrued Liabilities, Current 1.97M USD -17.6%
Contract with Customer, Liability, Current 1.93M USD +49.8%
Liabilities, Current 7.7M USD -23.9%
Contract with Customer, Liability, Noncurrent 2.02M USD +23.5%
Operating Lease, Liability, Noncurrent 659K USD -27.3%
Other Liabilities, Noncurrent 145K USD +40.8%
Liabilities 14.9M USD -7.75%
Accumulated Other Comprehensive Income (Loss), Net of Tax 539K USD +50.1%
Retained Earnings (Accumulated Deficit) -245M USD -5.34%
Stockholders' Equity Attributable to Parent 12.1M USD -32.3%
Liabilities and Equity 27M USD -20.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.47M USD +17.8%
Net Cash Provided by (Used in) Financing Activities 3.66M USD
Net Cash Provided by (Used in) Investing Activities -8K USD +81%
Common Stock, Shares Authorized 141M shares 0%
Common Stock, Shares, Issued 18.4M shares +33.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 161K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.89M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 48K USD +2.13%
Deferred Tax Assets, Valuation Allowance 58.3M USD +7.91%
Operating Lease, Liability 1.09M USD -13.9%
Depreciation 414K USD +79.2%
Payments to Acquire Property, Plant, and Equipment 8K USD -81%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.2M USD +26.1%
Lessee, Operating Lease, Liability, to be Paid 1.2M USD -12.7%
Property, Plant and Equipment, Gross 5.17M USD -8.86%
Operating Lease, Liability, Current 430K USD +20.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 432K USD +7.46%
Lessee, Operating Lease, Liability, to be Paid, Year One 483K USD +14.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +55.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 115K USD +0.88%
Lessee, Operating Lease, Liability, to be Paid, Year Three 41K USD -88.3%
Deferred Tax Assets, Operating Loss Carryforwards 52.4M USD +7.41%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.89M USD +165%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Additional Paid in Capital 256M USD +2.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 406K USD -1.93%
Share-based Payment Arrangement, Expense 1.58M USD -34.2%
Interest Expense 247K USD +2.49%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%